CSE1L Matched Antibody Pair (303) (APMAB-303LY)

Tunccan, T., Duzer, S., Dilek, G., Yuksel, U. M., Cetiner, H., Kılıc, C., ... & Duran, A. B. (2021). The role of CSE1L expression in cervical lymph node metastasis of larynx tumors. Brazilian Journal of Otorhinolaryngology, 87, 42-46.

Zhang, X., Zhang, X., Mao, T., Xu, H., Cui, J., Lin, H., & Wang, L. (2021). CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway. Journal of Cancer, 12(10), 2797.

Luo, Y., Qu, X., Kan, D., & Cai, B. (2021). The microRNA-451a/chromosome segregation 1-like axis suppresses cell proliferation, migration, and invasion and induces apoptosis in nasopharyngeal carcinoma. Bioengineered, 12(1), 6967-6980.

Zhou, Y., Zhou, Q., Li, L., Gu, Y., Sun, X., Wang, S., & Wang, X. (2021). Functional regulation of human trophoblast cells by CSE1L. The Journal of Maternal-Fetal & Neonatal Medicine, 34(10), 1598-1605.

Zhou, S., Zhang, M., Zhou, C., Meng, Y., Yang, H., & Ye, W. (2021). FLVCR1 Predicts Poor Prognosis and Promotes Malignant Phenotype in Esophageal Squamous Cell Carcinoma via Upregulating CSE1L. Frontiers in oncology, 11, 975.

Lin, H. C., Li, J., Cheng, D. D., Zhang, X., Yu, T., Zhao, F. Y., ... & Yao, M. (2021). Nuclear export protein CSE1L interacts with P65 and promotes NSCLC growth via NF-κB/MAPK pathway. Molecular Therapy-Oncolytics, 21, 23-36.

Nagashima, S., Maruyama, J., Honda, K., Kondoh, Y., Osada, H., Nawa, M., ... & Hata, Y. (2021). CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells. Journal of Biological Chemistry, 297(1).

Wang, Y. S., Peng, C., Guo, Y., & Li, Y. (2020). CSE1L promotes proliferation and migration in oral cancer through positively regulating MITF. Eur Rev Med Pharmacol Sci, 24(10), 5429-5435.

Dong, Q., Li, X., Wang, C. Z., Xu, S., Yuan, G., Shao, W., ... & Zhu, B. (2018). Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing. Proceedings of the National Academy of Sciences, 115(17), E4013-E4022.

Cheng, D. D., Lin, H. C., Li, S. J., Yao, M., Yang, Q. C., & Fan, C. Y. (2017). CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival. Scientific reports, 7(1), 1-13.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-CSE1L Recombinant Antibody (CBXC-2579)

Mouse Anti-CSE1L Recombinant Antibody (CBWJC-3164)

Mouse Anti-CSE1L Recombinant Antibody (729)

Mouse Anti-CSE1L Recombinant Antibody (2C10)

Mouse Anti-CSE1L Recombinant Antibody (1C4)

Mouse Anti-CSE1L Recombinant Antibody (8J103)

Mouse Anti-CSE1L Recombinant Antibody (1E4)

Mouse Anti-CSE1L Recombinant Antibody (3D8)

Mouse Anti-CSE1L Recombinant Antibody (CBYY-C2898)

Mouse Anti-CSE1L Recombinant Antibody (30F12)

Isotype control